Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 41 results
Filters: First Letter Of Last Name is L  [Clear All Filters]
Found 41 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

L

La Rosa AM, Harrison LJ, Taiwo B, et al. "Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study." Lancet HIV. 2016;3(6):e247-58.
Labo N, Miley W, Benson CA, Campbell TB, Whitby D. "Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy." AIDS. 2015;29(10):1217-25.
Lalama CM, Jennings C, Johnson VA, et al. "Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity." J. Clin. Microbiol.. 2015;53(8):2659-66.
Landovitz RJ, Tran TTien T, Cohn SE, et al. "HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States." AIDS Behav. 2016.
Lederman MM, Miller V, Weller I, Deeks SG. "A new approach for 'deep salvage' trials in advanced HIV infection." AIDS. 2007;21(12):1503-6.
Lederman MM, Penn-Nicholson A, Stone SF, Sieg SF, Rodriguez B. "Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption." Curr Opin HIV AIDS. 2007;2(1):56-61.
Lederman MM, Penn-Nicholson A, Cho M, Mosier D. "Biology of CCR5 and its role in HIV infection and treatment." JAMA. 2006;296(7):815-26.
Lederman MM, Smeaton L, Smith KY, et al. "Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138." J. Infect. Dis.. 2006;194(12):1677-85.
Lederman MM, Margolis L. "The lymph node in HIV pathogenesis." Semin. Immunol.. 2008;20(3):187-95.
Lee SA, Mefford JA, Huang Y, et al. "Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans." AIDS. 2016;30(11):1807-15.
Lee AJ, Bosch RJ, Evans SR, et al. "Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen." J. Neurovirol.. 2015;21(2):210-8.
Leger PD, Johnson DH, Robbins GK, et al. "Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384." J. Neurovirol.. 2014;20(3):304-8.
Lehmann DS, Ribaudo HJ, Daar ES, et al. "Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols." Pharmacogenet. Genomics. 2015;25(2):51-9.
Lennox JL, Landovitz RJ, Ribaudo HJ, et al. "Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial." Ann. Intern. Med.. 2014;161(7):461-71.
Li JZ, Paredes R, Ribaudo HJ, et al. "Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis." JAMA. 2011;305(13):1327-35.
Li B, Verma SS, Veturi YC, et al. "Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression." Pac Symp Biocomput. 2018;23:448-459.
Li JZ, Chapman B, Charlebois P, et al. "Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy." PLoS ONE. 2014;9(3):e90485.
Li L, Eron JJ, Ribaudo H, Gulick RM, Johnson BA. "Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095." J Am Stat Assoc. 2012;107(498):542-554.
Li JZ, Brumme CJ, Lederman MM, et al. "Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial." PLoS ONE. 2012;7(3):e34134.
Li JZ, Brumme ZL, Brumme CJ, et al. "Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial." J. Infect. Dis.. 2011;203(7):976-83.
Li JZ, Paredes R, Ribaudo HJ, et al. "Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure." AIDS. 2012;26(2):185-92.
Li JZ, Heisey A, Ahmed H, et al. "Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study." AIDS. 2014;28(18):2649-57.
Li JZ, Etemad B, Ahmed H, et al. "The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption." AIDS. 2016;30(3):343-53.
Li JZ, Christensen JA, Wang H, Spritzler J, Kuritzkes DR. "Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption." J. Acquir. Immune Defic. Syndr.. 2012;61(1):19-22.
Li JZ, Paredes R, Ribaudo HJ, et al. "Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure." J. Infect. Dis.. 2013;207(6):893-7.
Linas BP, Wang B, Smurzynski M, et al. "The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort." J. Viral Hepat.. 2011;18(7):506-12.
Liu D, Yu J, Chen H, Reichman R, Wu H, Jin X. "Statistical determination of threshold for cellular division in the CFSE-labeling assay." J. Immunol. Methods. 2006;312(1-2):126-36.
Liu H, Wilson IB, Goggin K, et al. "MACH14: a multi-site collaboration on ART adherence among 14 institutions." AIDS Behav. 2013;17(1):127-41.
Livingston EG, Cohn SE, Yang Y, et al. "Lipids and lactate in human immunodeficiency virus-1 infected pregnancies with or without protease inhibitor-based therapy." Obstet Gynecol. 2007;110(2 Pt 1):391-7.
Lockman S, Hughes M, Sawe F, et al. "Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial." PLoS Med.. 2012;9(6):e1001236.

Pages